ArticleRSC advances2020
Tb(iii)-doped nanosheets as a fluorescent probe for the detection of dipicolinic acid.
Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 26 citations in OpenAlex.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A new fluorescent probe based on terbium(iii)-doped nanosheets was designed for detecting low-levels of dipicolinic acid (DPA), a biomarker of bacterial spores. The ability to detect ultra-low concentrations of DPA is therefore of great significance. First, Tb(iii)-doped ytterbium hydroxide nanosheets were obtained by mechanical exfoliation from layered rare-earth hydroxide (LRH) materials. The morphology of the as-synthesized nanosheets was studied by transmission electron microscopy and atomic force microscopy. The Tb(iii)-doped nanosheets are demonstrated to be highly sensitive to DPA, which remarkably enhances Tb(iii) luminescence intensities at a wavelength of 544 nm. Furthermore, Tb(iii) emission increases linearly with DPA concentration. Selectivity studies were conducted by adding different competing aromatic ligands to the sensing solution; however, their fluorescence responses were observed to be negligibly small in comparison with that of DPA. Our findings provide a basis for the application of Tb(iii)-doped nanosheets for accurate, sensitive, and selective monitoring of DPA as a biomarker of anthrax.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.